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1. Introduction   
A number of patients with ischemic cerebrovascular stroke suffer a progressive 
deterioration secondary to massive cerebral ischemia, edema, and increased intracranial 
pressure (ICP). The evolution is often fatal. Stroke is the second – leading cause of death 
worldwide. Life-threatening, complete middle cerebral artery (MCA) infarction occurs in up 
to 10% of all stroke patients, and this may be characterized as massive hemispheric or 
malignant space – occupying supratentorial infarcts. Malignant, space – occupying 
supratentorial ischemic stroke is characterized by mortality up to 80%, several reports 
indicated a beneficial effect of hemicraniectomy in this situation, converting the closed, rigid 
cranial vault into a semi open.    
The main cause of death encountered in these patients is severe postischemic brain edema 
leading to raised intracranial pressure, clinical deterioration, coma and death. The result is 
dramatic decrease in ICP and a reversal of the clinical and radiological signs of herniation. 
For these reasons, decompressive craniectomy has been increasingly proposed as a life-
saving measure in patients with large, space-occupying hemispheric infarction.  Recent 
successes with intra-venous and intra-arterial thrombolytic therapy have resulted in an 
increased awareness of stroke as a medical emergency. Thus, increasing numbers of patients 
are being evaluated in the early hours following the ictal event. In the process of gaining 
more experience in the early management of patients with acute ischemic stroke, it has 
become clear that in a number of these patients a progressive and often fatal deterioration 
secondary to mass effect from the edematous, infarcted tissue occurs. An increasing body of 
experimental and clinical evidence suggests that some of these patients may benefit from 
undergoing a decompressive craniectomy. But, the timing and indications for this potential 
lifesaving procedure are still debated.  
The objectives of this chapter are;  
• To help better define the selection criteria for performing the surgery in case of 
supratentorial infarctions,  
• To assess the immediate outcome in terms of time conscious recovery and survival  
• To assess long term outcome and quality of life, using standard and functional 
assessment scales 
Complications have been reported in the literature when hemicraniectomy has been 
completed after cerebral infarction. Malignant cerebral ischemia occurs in a significant 
number of patients who undergo emergency evaluation for ischemic stroke. This patient 
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population can be identified by early clinical and neuroimaging characteristics. In some of 
these patients, Decompressive Craniectomy appears to be a life-saving procedure. If 
craniectomy is performed early, especially in young patients, a satisfactory functional 
outcome can be achieved in a significant proportion of cases. Clinical experience, however, 
demonstrates that even in such patients, an acceptable functional outcome can be achieved 
after surgery if some preservation of speech is present at the time of intervention.  
Additional studies will have to be mounted to analyze in more detail these implications. 
Survival after Decompressive Craniectomy for MCA infarction is better than that reported 
after medical management alone. Early hemicraniectomy based on radiographic and clinical 
criteria, but before signs of brain stem herniation, has been proposed as a means of 
improving outcomes. 
2. Historical background 
Decompressive craniectomy procedures have been used to relieve increased ICP and 
cerebral oedema caused by a variety of pathological events. This technique (decompressive 
craniectomy) first applied in 1905. (10)  In 1905, Cushing reported the use of this procedure 
to relieve the pressure caused by the growth of an intracranial tumour. (1, 39, 66) Since then, 
surgical decompression has been reported as a treatment option for traumatic head injury, 
(24, 26, 53, 42) subdural haematoma, (9, 56, 38) oedema resulting from vasospasm secondary 
to subarachnoid haemorrhage, (17) encephalitis, (39, 63) intracerebral haematoma, (13) 
cerebral venous and dural sinus thrombosis, (69) cerebellar infarction, (28, 31, 59) and 
supratentorial cerebral ischemia. (65, 45)  
Non randomized and randomized control data published are reviewed and data are 
analyzed, enrolling result from recent and earlier studies.  
In the 1950s and 60s, a number of reports were published in which the authors described 
cases of massive cerebral ischemia accompanied by acute and severe brain swelling. (1) 
These cases were often fatal, with the oedema caused by the infarct producing a 
“pseudotumour” increasing in pressure within the cranial vault. (44) In 1968, Greenwood 
used surgical intervention in the treatment of such cases, which decreased the mortality rate 
to below 50% as reported, (24) in his series of 9 patients with acute infarction involving the 
MCA or ICA, decompressive hemicraniectomy as well as resection of the necrotic 
parenchyma were performed. Six of these patients survived, although 3 suffered 
postoperatively from severe disability. In their report in 1971, Kjellberg and Prieto described 
a bifrontal decompressive craniectomy procedure for the treatment of a massive infarction; 
however, the patient did not survive. (41) In 1981, Rengachary and co-workers reported the 
first cases in which straightforward craniectomy were undertaken, without removal of 
necrotic brain tissue. (57) Since that study, more additional cases of hemicraniectomy and 
some with bilateral craniectomy have been reported in the treatment of massive cerebral 
ischemia. (50) Significant retrospective data support the hypothesis that decompressive 
hemicraniectomy decreases mortality rates due to this disease entity. Three randomized 
controlled studies shed light on these issues and enhance the quality of evidence revolving 
around this procedure. 
3. “Malignant” cerebral infarction  
Ischemic cerebral infarction is associated with a high rate of morbidity and mortality, which 
are highest when lesions involve the trunk of one or more of the main cerebral vessels. In 
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fact, occlusion of either the distal Internal Carotid Artery (ICA) or proximal (MCA) trunk 
has been characterized as a “malignant” stroke in both clinical and animal studies, and these 
are the reason why we are considering this topic in relation with brain infarction in MCA 
territory. (15, 27) Of all cases with supratentorial infarctions in which an autopsy is 
performed, 13% are shown to suffer from severe brain swelling after an infarction involving 
the entire distribution of the ICA or MCA. (46, 49) Severe cerebral oedema can lead to 
herniation of cerebral structures through the tentorium or falx, as well as the brainstem 
structures through the foramen magnum. In fact, transtentorial herniation has been cited as 
the probable cause of death in many of these cases of malignant stroke. Bounds et al 
reviewed 100 autopsy cases of patients in whom an infarction involving the ICA distribution 
had been diagnosed. (5) Thirty-one patients died of tentorial herniation, which was the only 
neurological cause of death in all the cases reviewed. 
The prognosis for patients who suffer a “malignant” cerebrovascular accident (CVA) is 
poor, with death occurring usually within the first 4 to 5 days. In this subset of patients, a 
mortality rate of 78% (estimated to be between 50% - 78%) was observed, (27) all deaths 
were attributed to transtentorial herniation, which occurred within 2 to 7 days (median 4 
days). Similarly, in another set of data 81% of patients with malignant CVA died, and all 
deaths occurred within 5 days and were caused by herniation, (62, 64) given the poor 
prognosis in these patients, it is of critical importance to recognize imaging or clinical 
characteristics suggestive of such a progressive and rapid deterioration. In patients who 
suffer a malignant CVA the clinical course is generally predictable. The clinical course in 
these patients is uniform, with clinical deterioration developing within the first 2 to 3 days 
after stroke.  Presenting symptoms may include the sudden onset of hemiplegia, 
homonymous hemianopsia, forced eye and head deviation toward the lesion side, and 
aphasia. Precipitous coma and papillary dilation usually occur together following the initial 
symptoms, (7, 12) in the absence of further intervention, death occurs. 
To establish objective criteria for aggressive intervention, many investigators have measured 
intracranial pressure (ICP) once significant clinical deterioration is apparent. In an early 
study patients in whom ICP values were greater than 15 mm Hg did not survive the 
malignant infarct. (61) In subsequent studies other authors have shown that a fatal outcome 
occurred in most cases when the level was greater than 30 mm Hg. (7, 29, 51, 59, 74) In 
addition to clinical findings, neuroimaging criteria can help to identify those patients at 
particular risk for a malignant infarction in the early phase of their stroke. In patients with 
malignant CVA, a large area of parenchymal hypodensity in the MCA territory is often 
visualized on the admission CT scans (Figure 1). (59, 64, 74, 78)   
With progressive clinical deterioration, CT-demonstrated signs may also include mass 
effect, effacement of the basal cisterns, compression of the ventricular system, a shift of 
midline structures, (78, 74) and herniation of tissue through the falx, foramen magnum, or 
tentorium. These patients present clinically with progressive deterioration of consciousness 
within the first 2 days. Thereafter, symptoms of transtentorial herniation occur within 2 to 4 
days after onset of stroke. This clinical presentation is accompanied by early CT signs of 
major infarct during the first 12 hours after stroke, (74) as no model of medical treatment has 
been proven superior to the others, treatment options may vary, depending on each clinic 
protocol. The value of conventional therapies in this condition, as in others of raised ICP, 
consisting of artificial ventilation, osmotherapy, and barbiturate administration, has been a 
subject of debate.  
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Fig. 1. CT scan demonstrating the R MCA territory infarction 
4. Rationale for decompressive craniectomy and experimental studies 
Cerebral ischemia results in oedema formation in and around the ischemic area, the larger 
the area of the infarction, the greater the extent of oedema. In the case of malignant CVA, the 
entire vascular distribution of the MCA, and possibly the anterior cerebral artery, is 
compromised. A severe oedematous response ensues throughout a large area. (61) Oedema 
is responsible for the parenchymal hypodensity that is demonstrated on CT scanning. (37, 
56) One of the fundamental pathophysiological processes after cerebrovascular stroke is the 
development and propagation of an escalating cycle of brain swelling and an increase in 
ICP. The goals of the clinical management consist of interrupting this cycle by controlling 
ICP and maintaining cerebral perfusion pressure and cerebral blood flow to avoid brain 
ischemia. This management strategy has been developed as a result of reported strong 
correlations between uncontrollable high ICP and high rates of morbidity and mortality. The 
relationship between high ICP and poor outcome has been demonstrated consistently in 
both single-centre and multicenter studies and the ability to bring elevated ICP under 
control has long been considered a requirement for improving outcome of patients with 
severe head injuries. Progressive brain oedema and the exacerbating effect it has on 
increasing ICP can cause the area of damaged brain to extend. Within the confined cranial 
vault, the oedematous tissue places pressure against surrounding normal parenchyma. This 
is evidenced by the changes seen on CT scanning (Figure 2). 
Intracranial hypertension results in decreased cerebral perfusion pressure and therefore 
decreasing blood supply throughout the cerebrum. Because of the increase in mechanical 
pressure and ICP, other major cerebral vessels may be compressed by the expanding tissue, 
against dural edges or against the skull. The result is secondary ischemia and a further 
expansion of the infracted area. (6)    
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Fig. 2. CT scan on day one, demonstrating evolving R MCA infarction with mass effect and 
compression of the ventricular system. Clinical examination revealed right midriazis 
Proposed as a life-saving procedure, increasing experimental and clinical evidence indicates 
that an early decompressive craniectomy can limit the extension of the infarcted area. From 
a mechanical perspective hemicraniectomy provides an immediate opening in the otherwise 
closed cranial vault. Therefore, compression of normal tissue is prevented or limited. The 
additional space created allows the tissue to expand through the bone defect, away from 
midline structures, so that CT-demonstrated changes normally observed when surgery is 
not performed like midline shift, decreased ventricular size, and herniation are minimized 
or completely resolved postoperatively. (37, 41, 61) As the cranial vault has essentially been 
expanded during surgery, there is an immediate decrease of ICP. The initial ICP values of 25 
to 60 mm Hg decreased by 15% once the bone flap was removed, and by 70% once the dura 
was opened, resulting in the normalization of the ICP after surgery. (32) Similar findings 
were demonstrated when performed a bilateral craniectomy. (78, 80) In 2 patients with 
ischemic CVA whose initial ICP values were 54.8 mm Hg and 20 mm Hg, respectively, 
removal of the bone flap caused a decrease in ICP to 35.5 mm Hg and 10 mm Hg, and 
opening of the dura caused a reduction to 4.4 mm Hg and 3 mm Hg, respectively. In the 
immediate postoperative period, the ICP values were recorded as 4.4 mm Hg and 10.2 mm 
Hg. A decrease in ICP allows for an increase in cerebral perfusion pressure, aiding blood 
flow to the ischemic area, optimizing circulation to the damaged area through collateral 
vessels. Because hemicraniectomy alone may improve blood flow in the ischemic area, 
surgical resection of the infracted tissue should not be conducted in these patients. Although 
such resection or “strokectomy” has been associated with postoperative improvements in 
some cases, it is impossible in all the cases to differentiate at surgery between ischemic 
tissue and necrotic tissue. (34, 57) Being poorly delineated from necrotic tissue, the ischemic 
area may possibly be damaged or removed upon resection of the infarct.  
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5. Timing and indications of surgery  
Hemicraniectomy has for a long time been used as a last resort to prevent impending death 
after all medical therapies have been attempted. The surgical procedure certainly preserves 
life, as evidenced by decreased mortality rates when compared with patients who undergo 
medical therapy alone. (61) In many of the reported cases, the symptoms of a severe herniation 
syndrome, fixed, dilated pupils, precipitous coma, cardiorespiratory difficulties and 
decerebrate posturing, were used to indicate the need for decompressive surgery. (37, 35, 40) 
Patients suffering malignant CVA receive antioedema medical treatment and 
hyperventilation or tissue plasminogen activator, (70) before considering a decompressive 
craniectomy. Usually, an initial reversal of symptoms, such as the degree of pupillary 
dilation, occurs with aggressive medical treatment. After its initial effectiveness, however, 
additional medical therapeutic efforts often fail to control or prevent herniation. In the case 
of massive cerebral ischemia, the effectiveness of such medical therapy is severely limited, at 
best, as evidenced by the high mortality rates observed in the absence of surgical 
intervention. In the case of stroke which is typically not treated surgically, physicians may 
wait too long to intervene surgically. Once the pupils are fixed and a deep coma has 
indicated an irreversible decline of cerebral function, surgery should not be performed. (57) 
 
Parameter Time of Surgery Patient’s outcomes. 1, 3, 6 months  
Age Mean ± SD 
Survival after one month (in percentage 
– of enrolled patients) 
Sex Percentage   
Territory of infarction 
MCA 
MCA/ ACA 
MCA/ PCA 
Number 
Barthel Index 
NIHSS score 
MRS score  
 
Hemisphere  Left / Right   
Pathological mechanism (if 
known) 
Emboli 
Dissection 
Other  
Number 
Functionally independent 
Mild to moderate disability 
Severely disabled  
Other related disease/ 
conditions 
  
On admission 
Barthel Index Score 
SSS score 
GCS 
Mean ± SD  
Time to surgery Mean   
Imaging findings CT/ MRI 
Signs of herniation before 
surgery 
Percentage  
Mortality rate (after surgery) Percentage  
Time on NCU Day   
Time of recovery    
NCU – Neurological Care Unit 
ACA – Anterior Cerebral Artery 
PCA – Posterior Cerebral Artery  
Table 1. Clinical and instrumental criteria used in evaluation of the patient  
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Evaluation of experimental findings suggests that, early surgical decompressive surgery for 
the treatment of massive cerebral ischemia may limit the extension of the infarction and 
reduce morbidity. (14, 21) Craniectomy can decrease the infarct volume and improve 
neurological outcome in a rat model of MCA occlusion when surgery is completed early (1 
hour postictus). (20) Similar results are found when surgery was completed 4 hours 
postictus. In the 4-hour treatment group, outcome and infarct volume were significantly 
better as compared with those observed in control animals and animals surgically treated at 
12, 24 and 36 hours postictus. Animals treated at these later time periods improved, but no 
significant differences were reported among these three groups and the control group. (14) 
When patients who suffer malignant CVA were surgically treated on average 21 hours 
postictus, there was a greater decrease in mortality rate and length of stay in the intensive 
care unit as compared with patients who underwent surgery an average 39 hours postictus. 
There was also a trend of improved Barthel Index (BI) scores demonstrated at follow-up for 
patients in the earlier surgical group. Several factors need to be considered to optimize both 
the timing and the indication for decompressive craniectomy (Table 1). (26, 30, 32, 48, 71, 72) 
6. Predictors of malignant cerebral edema  
Severely compressive brain edema is associated with significant mortality and morbidity. 
From a pathophysiological view, early intervention could minimize secondary ischemia of 
viable tissue around the infarcted area and possibly prevent herniation. Optimal utility of 
this procedure would require identifying the population that is most likely to benefit in a 
way that meets patient’s expectations as well as those of their families and caretakers. 
By using diffusion weighted MR imaging, a stroke volume greater than 145 cm3 within 14 
hours of onset of stroke symptoms has 100% sensitivity and 94% specificity for predicting 
the progression to malignant edema. (52) Additionally, in patients who suffered a massive 
MCA territory stroke, stroke volume greater than 50% of the MCA territory were identified, 
high white blood cell count, additional involvement of the anterior or posterior cerebral 
artery, systolic blood pressure higher than 180 mm Hg within 12 hours of stroke onset, and a 
history for the progression toward malignant edema. (36) Patients with an NIHSS score of 
20 or greater on admission or who present with nausea or emesis are at high risk for 
developing malignant cerebral edema. (43) In addition to clinical and radiographic risk 
factors, serum levels of the astroglial protein S100B have been shown to be predictive of 
malignant cerebral edema with 94% sensitivity and 83% specificity (for a value of 1.03 mg/L 
at 24 hours from the ischemic event). (19) This may become a useful monitoring tool at 
crucial clinical time points at which the development of cerebral edema is believed to be an 
imminent possibility, once a commercially available bedside kit is available. 
7. Time window for surgery 
The question of the optimal time window for intervention has not yet been completely 
elucidated. (4, 26, 30, 32, 48, 71, 72) Although the pooled data from the European trials seem 
to show benefit from early surgery, only a small number of patients was included in the late 
group in the HAMLET, (30) and definite conclusions cannot be drawn at this time. Another 
sours of data, did not demonstrate a difference in outcome based on timing. (26) Clear 
definition of a time window for intervention will be essential to creating treatment 
guidelines. With that purpose in mind, 2 additional randomized control trials (RCTs), The 
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North American HeADDFIRST (Hemicraniectomy And Durotomy on Deterioration From 
Infarction Related Swelling Trial), aimed to evaluate patient outcome after hemicraniectomy 
within 96 hours from symptom onset, the HeMMI trial (Hemicraniectomy for Malignant 
Middle cerebral artery Infarcts) in the Philippines is studied patient morbidity and mortality 
after decompressive surgery within 72 hours from symptom onset. 
8. Intracranial pressure monitoring 
Intracranial pressure monitoring has been recommended as a guide to surgical timing. (81, 
62) A measurement of greater than 25 mm Hg has been used despite attempts at medical 
therapy as an indicator for surgical intervention. (7, 59) Increased ICP measurements are 
preceded by the constellation of clinical signs and symptoms constituting the “malignant 
CVA syndrome;” thus, the usefulness of ICP monitoring in these cases has been questioned. 
But, brain tissue shifts rather than raised ICP are probably the most likely cause of the initial 
decrease in consciousness.  
9. Neuroimaging studies  
Extensive MCA infarction with oedema in greater than 50% of the MCA territory can be 
identified early after the ictal event on CT scans, and it is observed on the initial CT scan in 
approximately 69% of the reviewed cases by Hacke et al. (27) Parenchymal hypodensity in 
greater than 50% of the MCA territory is highly indicative of a progressive clinical course, 
leading to severe morbidity or death. With current, newer CT scanners, parenchymal 
hypodensity can be seen and followed soon after symptom onset (Figure 3). 
 
 
Fig. 3. CT scan demonstrating early CT findings of acute ischemic stroke (within 3 hours 
from onset) - slight changes, right sulci and Sylvian fissure effacement - effacement of R 
insular islands and structures of basal ganglia 
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In another set of data, most of the patients had at least two CT scans, one, within first 4 days 
after stroke and in some series within the first 12 hours after symptom onset, and the second 
one with the deterioration of symptoms and or after surgery (Figures 4 and 5). (64, 65)  
 
 
Fig. 4. CT scan, one day after hemicraniectomy (in which large frontoparieto-occipital bone 
was removed), revealing the resence of midline shift 
 
 
Fig. 5. CT scan, one month posthemicraniectomy, with resolution of previous midline shift 
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A midline shift of the cerebral structures is another phenomenon of increasing unilateral 
cerebral oedema that can be identified on CT scanning. The amount of midline shift  
was significantly different between survivors and nonsurvivors of malignant CVA. (59)  
In a study conducted to examine only the prognostic value of midline shift, it was 
suggested that at 32 hours after the occurrence of cerebral infarction, a shift of the third 
ventricle greater than 4 mm was indicative of a fatal outcome. (23) Regardless of its 
potential for prognostic significance however, midline shift is not visualized as early on 
CT scanning as is parenchymal hypodensity (Figure 1). Early changes demonstrated on 
CT scans are also an indicator of the viability of collateral circulation. Cerebral 
Angiography was performed (Figure 6) in patients in whom stroke was demonstrated 
early with CT scanning. (74) 
 
 
 
 
 
Fig. 6. R ICA AP angiogram reveals absence of R MCA - proximal occlusion 
Comparing the angiographic findings with those obtained using CT scanning, the authors 
observed that parenchymal hypodensity in greater than 50% of the MCA territory was 
predictive of poor collateral circulation, as evidenced by the angiographic study. (74) These 
findings are important, because in patients with adequate collateral circulation, 
decompressive hemicraniectomy may not be necessary.  
From neuroradiological studies it has been well recognized that “early visual radiolucency” 
in the CT examination is a negative outcome predictor. Continued refinements of newer 
imaging techniques such as diffusion / perfusion magnetic resonance will lead to an earlier 
identification of those patients more likely to benefit from early decompressive craniectomy. 
(Figures 7 and 8) 
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Fig. 7. MRI T2-weight diffusion, revealing R MCA territory infarction with early cytotoxic 
oedema 
 
 
Fig. 8. MR angiography revealing the absence of flow - related enhancement in the R MCA. 
Confirming persistent proximal occlusion of R MCA. 
10. Patient age and surgical age limit  
The age of patients undergoing surgical intervention reported in the reviewed series ranged 
from 11 to 70 years of age. Based on data provided in the literature, it was impossible to 
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determine if a certain age range of patients benefits more from surgical decompression. 
Most investigators, however, noted that they are more aggressive in performing 
hemicraniectomy in young patients in whom CVA has occurred and that the young seemed 
to benefit more from the procedure. By dividing patients by age in those younger than, and 
older than 50 years of age, it is found that patients under the age of 50 years made a good 
functional outcome (Barthel Index scores > 60 [100 = independent, 60-95 minimum 
assistance, and < 60 = dependent]), but not at all the patients over 50 years of age was this 
observed at follow-up examinations. (7) In theory and in practice, it would seem that 
younger patients with ischemic stroke would benefit from early decompressive surgery for 
the following reasons:  
• Their brains are less atrophied, allowing less room for oedematous expansion within 
the cranial vault. Individuals aged 50 years and younger have been identified as 
benefiting more from bilateral decompressive craniectomy in cases of subarachnoid 
haemorrhage because of their unatrophied brains, as compared with those over 50 years 
of age.  
• The ventricular system in younger persons is smaller than in older persons.   
• It has been proposed that the oedematous response to ischemia is greater in younger 
individuals.   
Randomized trials to date have focused on patients 60 years of age and younger, thus 
leaving us with very few data regarding patients older than 60 years of age. The HAMLET 
displayed conflicting results with previous review series (30) with a trend toward better 
outcome in the upper age categories (51–61 years). These results raised questions about the 
existence of an age limit for surgical benefit. The DESTINY RCT will shed more light on the 
impact of surgery in patients older than 60 years. (33) In patients older than 60 years of age, 
assessing outcome following decompressive craniectomy of malignant MCA infarction, 
mortality rate and functional outcome, as measured by Barthel Index (BI) and modified 
ranking scale (mRS), were significantly worse in patients older than 60 years of age 
following decompressive craniectomy. (3) Age is an important factor to consider in patient 
selection for surgery. However, cautious interpretation of the results is required because the 
outcome scores that were used only measure physical disability, whereas other factors, 
including psychosocial, financial, and caregiver burden, should be considered in addition to 
age alone.  
11. Dominant hemisphere infarction 
As a rule, investigators in the past did not undertake surgery in patients with dominant 
hemisphere infarctions. The loss of communicative abilities and a plegic dominant upper 
extremity were judged to be too damaging. Analysis of recent evidence suggests that 
considering a dominant hemisphere infarction to be a contraindication to surgery may be 
too harsh a criterion. (60, 65) Functionally, the patients with the dominant hemisphere 
infarct who underwent hemicraniectomy were not significantly different from those patients 
who underwent craniectomy after CVA in the nondominant hemisphere. Therefore, surgery 
can be considered in patients with dominant hemisphere infarction, especially if some 
residual language function is present at admission.  
While the fear of complete aphasia was classically the reason behind the refusal to operate 
on large dominant hemispheric strokes, data have suggested that nondominant hemispheric 
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injuries leading to serious depression and neglect can be as disabling as aphasia during the 
rehabilitation process. (76) Additionally a subset analysis in the DECIMAL trial showed no 
difference in the mRS scores of survivors with or without aphasia at 1 year; in addition, all 
surgical survivors agreed with the decisions to undergo surgery when asked retrospectively, 
including patients still experiencing aphasia. (72) Stroke laterality and its correlation with 
outcome (29, 30, 33, 34, 71) have also been the subject of subgroup analysis in other trials 
and controlled and uncontrolled studies have shown no predicative value for outcome 
related to laterality.  
There has been interest in identifying which patients will develop malignant cerebral 
oedema after massive infarcts, patients at high risk (Table 2).  
 
 
Inclusion criteria  Exclusion criteria  
Age 18 - 60 years Prestroke mRS score ≥ 2 
NIHSS score nondominant hemisphere > 18 
                            dominant hemisphere > 20 
Prestroke score Barthel Index < 95 
Imaging - documented unilateral infraction. 
MCA at least 2/3 of territory and at least part 
of basal ganglia. 
± Additional infarctions in ACA or PCA 
territory. Ipsilateraly.  
GCS < 6 
Time – onset of symptoms bilateral - pupils fixed and dilated  
 Other brain related diseases  
 Haemorrhagic transformation of the 
infarct 
 Life expectancy < 3 years 
 Other related disease/ conditions - 
affecting outcome.  
Especially coagulopathy/ systemic 
blooding disorders.  
Pregnancy. 
 Contraindication for anaesthesia 
Table 2. Criteria proposed to use for inclusion/ exclusion of patients and clinical outcome.  
12. Surgical technique, results and limits 
12.1 Operative technique 
Hemicraniectomy for supratentorial infarction usually involves aggressive bone removal to 
alleviate better the symptoms of malignant cerebral oedema. The need for a radical 
approach, extension of bone removal, was recognized in the event of severe posttraumatic 
cerebral oedema, this was echoed in the case of massive cerebral ischemia when a few of 
initial surgically treated patients harboured a bone defect that was too small, not providing 
adequate space for decompression and resulting in brain herniation through the skull 
opening. (25, 60) Prolapsed of the oedematous brain through the edges of the craniectomy 
defect, with possible exacerbation of brain damage is one of the possible limitations of 
decompressive craniectomy. In the case of cerebral infarction, however, this phenomenon 
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does not result in significant increased cerebral damage or venous stasis, because most likely 
the protruding tissue is already necrotic.  
In the event of massive cerebral ischemia, the frontal, temporal, and parietal bones overlying 
the infracted hemisphere are removed. The dura is incised and reflected. A dural expansion 
graft of pericranium, lyophilized cadaver dura, homologous temporal fascia, or sintetic 
material is loosely sutured to the dura edges to prevent cortical adhesions. The dura is fixed 
to the craniectomy edges to prevent or limit epidural bleeding, and the temporal muscle and 
skin flap are reapproximated and sutured or stapled into place. The bone flap may be frozen 
and preserved or instead a fabricated artificial material can be used (e,g titanium), to close 
the bone defect, cranioplasty is then performed at a later date, when functional recovery has 
stabilized.  
A technical note “In-window” craniotomy and “bridgelike” duraplasty as an alternative to 
decompressive hemicraniectomy has been lately introduced as an alternative, concluding 
that decompressive surgery, which uses an in-window craniotomy that gradually opens 
according to the intracranial pressure, is an alternative solution for deploying autologous 
material. The procedure has the advantage of obviating the need for a second surgical 
procedure to close the bone defect, and thus preventing the metabolic cerebral impairment 
associated with the absence of an overlying skull. (73) 
By studying the impact of craniectomy size, shape, and location on parenchymal 
hemorrhagic and ischemic lesions, postoperative bleeding, and mortality, and 
interestingly found a 70% rate of hemicraniectomy-associated infarcts and hemorrhage. 
Bleeding was associated with a small craniectomy size and sharp bone defects. 
Parenchymal hemorrhage was the only factor that statistically affected mortality rate, 
with only 55% of patients surviving compared with 80% in the absence of hemorrhage, 
with a recommendation for craniectomy size in a diameter larger than 12 cm. This 
conclusion is validated by the fact that some studies suggest that doubling the diameter 
from 6 cm to 12 cm potentially increases the decompressive volume from 9 to 86 ml. (75, 
79) Ideally, hemicraniectomy should be performed in the frontotemporoparietal region 
and reach the floor of the middle cranial fossa. The midline should be spared to avoid 
injury to the superior sagittal sinus. 
12.2 Results of craniectomy  
For more than 50 years, (1, 10, 39, 66) patients have been selected from case reports or series; 
range age 10 to 76 years, predominantly male patients, with a good outcome for up to 60% 
of the patients, several studies have shown that decompressive surgery is a possible 
treatment strategy for increased ICP after severe supratentorial stroke.  
Although increasing numbers of studies have reported encouraging results after 
decompressive craniectomy for ischemic stroke, these studies are mostly limited to case 
series without a control group, a summery has is shown in a publication. (50) Study shows 
that mortality is lower in the surgically treated group compared with a higher mortality rate 
in the control group – medically treated, and with a better outcome in the surgically treated 
group. (60) 
As decompressive craniectomy can be a life-saving procedure in patients who will most 
likely be left with a significant neurological deficit, the operation has important ethical and 
psychological implications. Because of their altered level of consciousness, patients cannot 
directly provide consent and in such cases, informed consent has to be obtained from the 
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relatives. Psychological disturbances in this patient population were addressed, and mood 
disturbances were significant in patients who underwent decompressive craniectomy after 
right-sided hemisphere ischemic stroke, patients suffered severe depressive symptoms, and 
mild to moderate impairment was demonstrated. (7) 
In deciding when surgery is indicated, it is important to know that in general, clinical signs 
precede critically raised ICP, drowsiness is one of the major clinical symptoms of 
developing brain oedema (61) thus, ICP monitoring of this condition might be helpful in 
guiding further therapy. However, elevated ICP is not a common cause of initial 
neurological deterioration from large hemispheric stroke. (21)   
Even under full supportive therapy, the mortality rate is reported high (roughly 80%), and 
lately the effectiveness of many medical therapies such as chronic hyperventilation, 
osmotherapeutics, barbiturate therapy, has been challenged. (14, 20, 29, 34, 45) The clinical 
course of patients with severe supratentorial stroke is highly predictable, therefore, waiting 
for mesencephalic signs to occur potentially worsens prognosis. It was hypothesized that 
through decompressive surgery, the vicious circle of extensive oedema, which by elevation 
of ICP causes ischemia of neighbouring brain tissue and further infarction, may be 
interrupted. (14) This may then increase cerebral perfusion pressure and optimize 
retrograde perfusion of leptomeningeal collateral vessels, thus allowing functionally 
compromised but viable brain to survive. (21)  
The timing of surgery, hemisphere infarcted, presence of signs of herniation before surgery, 
and involvement of other vascular territories may not significantly affect outcome, to 
identify the patients most likely to benefit from hemicraniectomy, age may be a crucial 
factor in predicting functional outcome after hemicraniectomy in patients with large MCA 
territory infarction, as from different review of data. (26, 33, 47, 60) 
There are several limits to these reviews.  
12.3 What limits?  
These were data prior to RCTs but in the absence of randomized controlled data by that 
time, questions remained regarding optimal patient selection, timing of therapy, and 
prognosis.  
Waiting for signs of herniation may worsen prognosis because of irreversible mesencephalic 
injury. Early decompressive surgery may further improve outcomes in these patients, 
considering for surgery nondominant hemisphere or incomplete aphasia before 
deterioration. For the patients, surgically treated before the occurrence of clinical signs of 
herniation, within the first 24 hours after stroke onset, hemicraniectomy is an effective 
therapy for the condition of malignant MCA infarction. Most related complications 
associated with the operation were epidural haematoma, subdural haematoma, and 
hygromas. However, whether and when decompressive surgery is indicated in these 
patients is still a matter of debate but, younger patients may have better functional outcome 
even if undergoing decompressive craniectomy of the dominant hemisphere. (65) 
Given the unresolved questions regarding the role of decompressive craniectomy and 
appropriate patient selection, the following RCTs were conducted and designed, to 
investigate the efficiency of decompressive surgery: DECIMAL (Decompressive 
Craniectomy In MALignant middle cerebral artery infarcts) (72) DESTINY (DEcompressive 
Surgery for the Treatment of malignant INfarction of the middle cerebral arterY) (34, 71) and 
HAMLET (Hemicraniectomy After Middle cerebral artery infarction With Life-Threatening 
Edema Trial). (30) Not all the RCTs demonstrated statistical superiority of hemicraniectomy 
and failed to meet the primary end point. (71) 
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13. Surgery-related complications and the quality of life related surgery  
Complications have been reported.  
The outcomes of patients undergoing decompressive craniectomy may be impacted by the 
complications of the procedure, reported complications include inadequate decompression, 
infection, hemorrhage, and the development of contralateral fluid collections, postoperative 
epidural and subdural haemorrhage as well as hygromas has occurred. Furthermore, 
delayed sinking flap syndrome may result in headaches, seizure and focal neurological 
deficits and is typically cured by replacement of the bone flap. Similarly, hydrocephalus 
may develop in a delayed fashion. (7, 28, 29, 34, 45, 60, 65, 71, 77) 
Available data are in agreement on a reduction of the mortality rate, but the reported 
functional outcome was highly variable. Older age, more severe neurological deficit on 
admission, and longer duration of intensive care treatment and mechanical ventilation were 
significantly associated with worse disability (BI < 50). The health-related quality of life 
(QOL) was considerably impaired in the subscales of mobility, household management, and 
body care. Decompressive hemicraniectomy improves survival in patients with malignant 
MCA infarction when compared with earlier reports of conservative treatment alone. 
Functional outcome and QOL remain markedly impaired, especially among elderly patients 
and in those with a severe neurological deficit at admission. (18) Early death is a result of 
transtentorial herniation while delayed death is typically due to the medical complications 
of prolonged hospitalization including pneumonia and pulmonary emboli. (67) Although 
the impact on mortality appeared unequivocal in most studies. Surgical age limit has not yet 
been fully defined very few data exist to support hemicraniectomy for patients older than 60 
years. Data analysis, demonstrate significant mortality reduction in the surgically treated 
patients compared with those receiving medical treatment. Surgical decompression within 
48 hours of stroke onset reduces the risk of death and the risk of significant morbidity and 
showed a statistically significant reduction in severely disabled, bedridden patients (mRS 
score > 4), effect on severe disability (mRS score 5) and effect on moderate disability (mRS 
score 4). (72, 34, 30) 
Quality of life issues are difficult to put in proper perspective, studies help clarify some 
facets of this important subject. Future studies will need to focus more rigorously on the 
long-term quality of life in survivors and the neurological outcome. There exists a difficult 
balance between increasing survival and poor neurological outcome, which at the other end 
includes the subjective assessment of outcome and discussion with the patient and the 
family that should be held early, in the need for surgical decompression, while keeping in 
mind that RCTs reported a trend of reduced disability among survivors. (72, 34, 30, 55, 68) 
Data refer that most patients remain in a vegetative state after this intervention, (11) 
however other data conclude that decompressive hemicraniectomy improves survival in 
patients with malignant MCA infarction when compared with earlier reports of 
conservative treatment alone.  Functional outcome and QOL remain markedly impaired, 
especially among elderly patients and in those with a severe neurological deficit at 
admission. (3, 4, 8, 18, 33) 
14. Conclusions 
Malignant cerebral ischemia occurs in a significant number of patients who undergo 
emergency evaluation for ischemic stroke. The mortality rate in these patients is very high. 
Fatal outcome is usually related to progressive, severe cerebral oedema with brain 
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herniation and compression of critical brainstem structures. This patient population can be 
identified by early clinical and neuroimaging characteristics. In some of these patients, 
decompressive craniectomy appears to be a life-saving procedure. If craniectomy is 
performed early, especially in young patients, a satisfactory functional outcome can be 
achieved in a significant proportion of cases. Questions persist regarding the indications for 
such a procedure in patients with dominant infarctions. Clinical experience, however, 
demonstrates that even in such patients, an acceptable functional outcome can be achieved 
after surgery if some preservation of speech is present at the time of intervention.  
Best Medical Treatment or Optimal medical management for malignant edema due to stroke 
has not been standardized. Recommendations for medical management of stroke-related 
malignant edema included admission to the intensive care unit, osmotherapy with mannitol 
or glycerol, invasive monitoring of intracranial pressure, blood pressure control, elevation of 
the head to 30°, and maintenance of normothermia, normoglycemia, and normovolemia. 
Morbidity and mortality rates are high for this disease entity despite such aggressive 
measures. (30) Although decompressive craniectomy has been shown to significantly 
decrease mortality, high morbidity rates among survivors have tempered enthusiasm for 
this procedure. This reluctance has been most pronounced in elderly patients and those with 
dominant hemisphere infarcts. The span of the optimal operative time window when 
surgical decompression is superior to medical management alone is also subject to debate. 
(4)  
We hope that our findings will add to existing information on decompressive 
hemicraniectomy and help until further data are available. However, there are some 
unanswered questions and questions persist regarding the age and the indications for such a 
procedure in patients with dominant infarctions:  
• Which subset of patients will benefit maximally?  
• Which patients will survive with an unacceptable degree of functional dependency?  
• What is the optimal timing for surgery?  
MCA infarction with malignant edema is a devastating disease for which hemicraniectomy 
can play a positive role. 
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instance, a total of 22,000 cases of cerebrovascular diseases are reported each year in a country where life
expectancy should increase to 80 years in the near future. In such a situation, to have a book that includes in a
clear and summarized way, a group of topics directly related to the preclinical investigations advances and the
therapeutic procedures for the cerebrovascular disease in its acute phase constitutes a useful tool for the wide
range of the contributors to this affection's problems solution. In this group is included students, professors,
researchers, and health policy makers whose work represents one of the greatest social and human impact
challenges of the XXI century basic and clinical neurosciences.
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